CYTK

CYTOKINETICS, INCORPORATED

CYTK · CIK 1061983 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$88M
20182025
Net Income−$785M
20182025
Operating CF−$510M
20182025
Free Cash Flow−$535M
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$0.1B$0.0B$0.0B$0.1B$0.1B$0.1B$0.0B$0.0B
Cost of Revenue
Gross Profit
R&D Expense$0.4B$0.3B$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B
SG&A Expense
Operating Income$-0.6B$-0.5B$-0.5B$-0.3B$-0.2B$-0.1B$-0.1B$-0.1B
Net Income$-0.8B$-0.6B$-0.5B$-0.4B$-0.2B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-6.54$-5.26$-5.45$-4.33
EPS (Diluted)$-6.54$-5.26$-5.45$-4.33

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$1.4B$1.4B$0.8B$1.0B$0.8B$0.5B$0.3B$0.2B
Current Assets$0.9B$1.1B$0.6B$0.8B$0.5B$0.5B$0.2B$0.2B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Total Liabilities$2.1B$1.5B$1.2B$1.1B$0.6B$0.4B$0.3B$0.2B
Current Liabilities$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.7B$-0.1B$-0.4B$-0.1B$0.2B$0.1B$-0.0B$0.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$-0.5B$-0.4B$-0.4B$-0.3B$-0.1B$0.0B$-0.1B$-0.1B
Investing Cash Flow$0.0B$-0.6B$0.2B$-0.3B$-0.1B$-0.2B$-0.1B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.5B$0.9B$0.2B$0.5B$0.3B$0.2B$0.2B$0.0B